NEUROCHASE

Our mission is to accelerate the development and commercialization of innovative therapeutics for the central nervous system (CNS) by building the next-generation of interventional engineering tools for functional neurosurgery. Neurochase was founded by Professor Steven Gill to bring transformative targeted therapies to patients with neurological diseases using state of the art technology. Professor Gill is an Honorary Professor of Neurosurgery at the University of Bristol and a Consultant Ne... urosurgeon at Southmead Hospital, Bristol. He is a widely published, world-leading expert in Functional Neurosurgery having pioneered the targeting of novel brain structures to improve the treatment of Parkinson’s disease and tremor. He also carried out the first clinical trial of infusing GDNF directly into the brain which demonstrated the potential to reverse Parkinson’s disease. He is a prolific inventor and has, over the past 20 years, developed technology and software to facilitate highly accurate and safe targeting of deep brain structures using surgical robots.More